Puma Biotechnology terminates CCO Jeff J. Ludwig; no replacement named

PUMA BIOTECHNOLOGY, INC.

Terminated Jeff J. Ludwig as Chief Commercial Officer and employee on May 8, 2025.
Mr. Ludwig may receive severance per his employment offer letter contingent on signing a release within 60 days.
Company will not appoint a new CCO; responsibilities absorbed by existing sales and marketing personnel.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Jeff J. Ludwig

Chief Commercial Officer

PBYI · PUMA BIOTECHNOLOGY, INC.

Effective: 2025-05-08
Filed: May 9, 2025, 7:59 PM ET

On May 8, 2025, Puma Biotechnology, Inc. (the “Company”) terminated Jeff J. Ludwig as an employee and as its Chief Commercial Officer.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Jeff J. Ludwig was terminated as Chief Commercial Officer at PUMA BIOTECHNOLOGY, INC..

Action: terminated
Role: Chief Commercial Officer

Exact text from the filing

On May 8, 2025, Puma Biotechnology, Inc. (the “Company”) terminated Jeff J. Ludwig as an employee and as its Chief Commercial Officer.

View on SEC.gov

PUMA BIOTECHNOLOGY, INC. filing history →

Source: SEC EDGAR

accession 0001437749-25-015648

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.